Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Clinical trial NCT01469832 · COMPLETED
Trial details
- NCT number
- NCT01469832
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-13
- Primary completion
- 2015-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.